From the Division of Cardiology, Department of Internal Medicine, Feinberg Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, Ill. The authors have no relevant financial interest in this article.
Motor activity occurring during neurocardiogenic syncope can mimic true neurologic events.
To assess the prevalence and type of apparent neurologic events associated with tilt table testing.
The records of consecutive patients undergoing tilt table testing for the evaluation of syncope were reviewed. Patients underwent a 70° upright tilt for 40 minutes, followed by a 20-minute tilt while receiving isoproterenol hydrochloride. The results of tilt table tests were considered positive when clinical symptoms were reproduced in association with a decline in blood pressure. Clinical variables and neurologic events were analyzed.
Tilt table tests were performed on 694 patients during the study period, and the results were positive in 222 of them. Eighteen patients (8%) had apparent neurologic events during tilt table testing. Eleven patients (5%) had apparent tonic-clonic seizure–like activity, and 7 patients (3%) had non–tonic-clonic neurologic events, including focal seizures (n = 3), dysarthria or aphasia (n = 2), unilateral extremity dysesthesia (n = 1), and reproduction of temporal lobe epilepsy symptoms (n = 1). The patients with tonic-clonic seizure–like activity had a significantly lower systolic blood pressure reading at the termination of tilt table testing than all other patients whose tilt table test results were positive (P = .04). The heart rate at the time of test termination was significantly lower in the patients with tonic-clonic seizure–like activity and non–tonic-clonic neurologic events (P<.01) than in those with positive test results and no provoked neurologic events, and asystole was provoked more frequently in these 2 patient populations (P = .03).
Neurologic events are common during episodes of neurocardiogenic syncope, and this diagnosis should be considered in the evaluation of unexplained seizurelike activity.
NEUROCARDIOGENIC syncope is a common cause of transient loss of consciousness in the general population, accounting for 40% of all such events evaluated in the outpatient setting.1 Although the diagnosis of neurocardiogenic syncope is often correctly ascertained on the basis of classic signs and symptoms alone, some patients may be erroneously classified as having neurologic disease because seizurelike activity or focal neurologic deficits are observed during an event. Tilt table testing has emerged as a useful tool in the diagnosis of neurocardiogenic syncope and has been demonstrated to provoke seizurelike activity in up to two thirds of patients with clinically observed seizurelike activity who are unresponsive to standard antiepileptic therapy.2- 6 Also, symptoms consistent with apparent transient ischemic attacks have been reproduced by tilt table testing in a selected elderly population.7 In both groups, standard therapy for neurocardiogenic syncope abolished these symptoms. The results of these studies suggest that a portion of apparent neurologic events may actually have a neurocardiogenic cause. However, since the studies were drawn from highly select patient populations, they do not permit an assessment of the frequency with which neurocardiogenic syncope may present as apparent neurologic events in the general population.
Failure to identify the cause of clinical seizures is not uncommon and may lead to therapies that are ineffective and potentially harmful.8,9 Furthermore, misdiagnosis may result in a failure to prescribe appropriate therapy and could expose the patient to the risks of recurrent syncope and possible sudden cardiac death.10 The aim of the present study was to characterize the prevalence and characteristics of apparent neurologic events occurring during neurocardiogenic syncope.
The results of all tilt table tests performed at Northwestern Memorial Hospital, Chicago, Ill, for the evaluation of syncope over a 6-year period were reviewed. The results of tests performed for the evaluation of chronic fatigue symptoms or as follow-up to assess the efficacy of medical therapy were excluded. Positive test results, defined as a reproduction of the patient's clinical symptoms in association with a decrease in the systolic blood pressure level with or without relative bradycardia, were further analyzed.
Tilt table testing was performed with the patients in the unsedated, fasting state. The patients were connected to a standard cardiac monitor for continuous evaluation of heart rate and to a standard sphygmomanometer for blood pressure measurement that was determined every 3 minutes. An intravenous catheter was inserted through which normal saline at 30 mL/h was infused to maintain catheter patency. After baseline measurements of heart rate and blood pressure levels, each patient was positioned at a 70° angle from horizontal for up to 40 minutes on a tilt table with a footboard made for weight bearing (Tri W-G Inc, Valley City, ND). If syncope developed during the test, the table was rapidly lowered to the supine position. If the baseline tilt failed to yield a positive result, the patient was returned to the supine position for 5 minutes, and isoproterenol hydrochloride infusion was initiated at 2 ug/min. The dosage was increased by 1 ug/min to a maximum of 6 ug/min as needed to achieve a heart rate of greater than 100 beats/min and an increase of at least 25% above baseline. Upright tilt was then repeated for up to 20 minutes. A positive response was defined as syncope associated with hypotension with or without relative bradycardia.
Analyzed variables included patient age, sex, history of seizure, use of isoproterenol during protocol, duration of tilt table testing (at baseline and during isoproterenol infusion), initial and final heart rate and blood pressure reading, occurrence of asystole, and the type, if any, of neurologic events provoked. Asystole was defined as a pause lasting longer than 3 seconds. Tonic-clonic seizure–like activity was defined as tonic spasms with or without clonic movements occurring with loss of consciousness. Non–tonic-clonic neurologic events were defined as signs or symptoms consistent with a neurologic cause but not associated with tonic-clonic movements. The patients were divided into 3 groups for analysis: (1) those with positive tilt table test results with no provoked neurologic events, (2) those with positive tilt table test results with tonic-clonic seizure–like activity provoked, and (3) those with positive tilt table test results with non–tonic-clonic neurologic events provoked.
Comparisons of continuous variables between groups were performed with 1-way analysis of variance. Nominal variables were compared using χ2 analysis or Fisher exact test; P<.05 was considered statistically significant. Continuous variables are expressed as mean ± SD.
Follow-up was performed by review of medical records and through discussions with the patients' physicians. The study was approved by the institutional review board of Northwestern Memorial Hospital. Informed consent was obtained at the time of tilt table testing by an attending physician.
Tilt table tests were performed in 694 patients for the evaluation of syncope, and the results were positive in 222 patients (32%): 155 on baseline tilt (69.8%) and 67 (30.2%) with isoproterenol infusion. The duration of baseline tilt until a positive result was obtained was 26 ± 16 minutes, and the duration of isoproterenol tilt table testing until a positive result was obtained was 12 ± 10 minutes.
Eleven patients (5%) had tonic-clonic seizure–like activity provoked by tilt-table testing. Seven patients (3%) had other non–tonic-clonic neurologic events provoked by upright tilt, including focal seizure activity involving 1 extremity (n = 3), dysarthria or aphasia (n = 2), reproduction of unilateral extremity dysesthesia (n = 1), and reproduction of alteration of consciousness previously diagnosed as temporal lobe epilepsy (n = 1). All but 1 event resolved immediately or shortly after the patient's return to the supine position with no postictal state; the single probable neurologic event was a prolonged period of aphasia that was ultimately diagnosed as a transient ischemic attack. All the apparent tonic-clonic seizure–like activity or non–tonic-clonic neurologic events occurred with baseline testing without isoproterenol.
Comparison of the 3 groups of patients with positive tilt table test results (positive tilt table test results with no neurologic events provoked, positive tilt table test results with tonic-clonic seizure–like activity provoked, and positive tilt table test results with non–tonic-clonic neurologic events provoked) revealed no significant differences in patient age, sex distribution, or initial heart rate and blood pressure reading (Table 1). Patients with positive tilt table test results and tonic-clonic seizure–like activity had a significantly lower systolic blood pressure reading at the time of termination of tilt table testing (37 ± 38 mm Hg for patients with positive tilt table test results and tonic-clonic seizure–like activity vs 56 ± 41 mm Hg for patients with positive tilt table test results and non–tonic-clonic neurologic events vs 63 ± 32 mm Hg for patients with positive tilt table test results and no neurologic events; P = .04). There was no significant difference in the systolic blood pressure reading at the time of test termination between those patients with non–tonic-clonic neurologic events and those with no neurologic events (P>.05). The heart rate at the time of termination of testing was slower in patients with positive tilt table test results and tonic-clonic seizure–like activity and patients with positive tilt table test results and non–tonic-clonic neurologic events than in patients with positive tilt table test results and no neurologic events (38 ± 37 beats/min in patients with tonic-clonic seizure–like activity provoked, 37 ± 30 beats/min in patients with non–tonic-clonic neurologic events provoked, and 67 ± 26 beats/min in patients with no neurologic events provoked; P<.001) (Table 1). Asystole was more common in the patients with either type of provoked neurologic events, although the duration of asystole was not different among the 3 groups. A history of seizurelike activity, while rare, was significantly more common in patients in whom neurologic events were provoked on tilt table testing (0.5% in patients with positive tilt table test results with no neurologic events provoked, 18% in patients with positive tilt table test results and tonic-clonic seizure–like activity provoked, and 43% in patients with positive tilt table test results with non–tonic-clonic neurologic events provoked; P<.001). Before tilt table testing, 2 patients in whom tonic-clonic seizure–like activity was provoked by tilt table testing had been diagnosed as having tonic-clonic seizures. Of the patients with non–tonic-clonic neurologic events provoked by tilt table testing, 1 had been diagnosed as having tonic-clonic seizures, 1 as having temporal lobe epilepsy, and 1 as having focal seizures related to a prior subarachnoid hemorrhage. Antiepileptic therapy in these patients had failed to prevent recurrence of apparent neurologic events.
Selected neurologic evaluation, including electroencephalography (EEG), computed tomography, and magnetic resonance imaging, of the patients with either tonic-clonic seizure–like activity or non–tonic-clonic neurologic events failed to reveal a specific neurologic finding in any patient.
Treatment of patients with positive tilt table test results was advised, if clinically indicated, with a β-blocker as first-line therapy and a mineralocorticoid as second-line therapy. Long-term follow-up data were available on 13 patients. The duration of follow-up was 73.1 ± 29.4 months, with a range of 30 to 135 months. The patient with a prior diagnosis of temporal lobe epilepsy had a recurrence of his symptoms while taking 50 mg/d of atenolol; at a dosage of 100 mg/d, he has had no recurrences. No other patient in whom follow-up data were available subsequently had recurrent seizurelike or atypical events during therapy for neurocardiogenic syncope. One patient with a history of transient ischemic attacks who had transient dysarthria provoked by tilt table testing continued to have transient ischemic attacks during therapy. One patient who had seizurelike tonic clonic activity provoked by tilt table testing developed atrial fibrillation and had an embolic stroke 11 years after the index event, while another patient was diagnosed as having Alzheimer dementia 1 year after the index event.
The major findings of the present study are the relatively high frequency of tonic-clonic seizure–like activity and non–tonic-clonic neurologic events in patients with positive tilt table results who were undergoing evaluation for syncope and the observed differences in hemodynamic profiles between the 2 groups at test termination.
Prior studies of neurologic events during tilt table testing have generally involved patient populations selected for a history of seizures that are often refractory to antiepileptic drug therapy, with seizurelike activity reported in as many as 25% to 66% of such patients.5,6,11 The frequency of neurologic events that occur during tilt table testing in an unselected population has not been well established. However, the prevalence of such events has been reported in a population of individuals during phlebotomy, a procedure that is well known to induce neurocardiogenic syncope in susceptible individuals. In a study of blood donors, retrospective and prospective analyses yielded incidences of 11.9% and 41.6%, respectively, of convulsive movements during syncope.12 The variation between retrospective and prospective results may be partially attributed to increased attentiveness during the prospective study. Although these observations did not take place in the more controlled setting of a tilt table test laboratory, it does give some indication as to the frequency with which syncope is associated with seizurelike activity.
The present study demonstrates that the hemodynamic changes in uncomplicated neurocardiogenic syncope are less marked than when the event is associated with tonic-clonic seizure–like activity and non–tonic-clonic neurologic events. As in the current study, significant bradyarrhythmia has been reported with seizurelike activity during tilt table testing.6 In a prior report involving patients with apparent recurrent transient ischemic attacks that could be reproduced on tilt table testing, the systolic blood pressure readings at the time of symptoms were similar to those of our patients with non–tonic-clonic neurologic events.7
Although the tonic-clonic seizure–like activity that may occur during neurocardiogenic syncope may appear similar to epileptic seizures, the mechanism is distinct. Simultaneous EEG and tilt table testing shows nonepileptiform theta and delta wave slowing during syncope.13 In patients with convulsive movements during tilt-induced syncope, EEG demonstrates similar diffuse slowing without spike or spike-wave activity.11 The adjuvant use of EEG with tilt table testing has been used to differentiate epileptic seizure and tonic-clonic activity during vasodepressor syncope from seizures of psychogenic origin that lack significant hemodynamic or EEG changes.14,15
Upright tilt table testing with simultaneous transcranial Doppler blood flow analysis demonstrates that sudden and transient loss of consciousness occurs when cerebral perfusion decreases to approximately half of the baseline flow velocity in most patients.16 Measurement of brain tissue oxygenation with noninvasive spectroscopy has shown a similarly consistent threshold level of oxygen saturation below which syncope occurs.17 These results have led some authors to conclude that cerebral autoregulation is ineffective at the extremes of systemic blood pressure levels or that some individuals have inherently less autoregulatory control. Studies have also demonstrated paradoxical constriction of cerebral vessels during vasodepressor syncope, reinforcing the concept that there is a compounding cerebrovascular reflex in addition to the other hemodynamic effects during vasodepressor syncope. 18,19 The occurrence of seizurelike activity and other neurologiclike events with syncope does not necessarily suggest an underlying central nervous system derangement.
Tonic posturing and convulsive movements during syncope reflect a critical degree of cerebral hypoxia producing a transient decorticate response. Whether the convulsive movements are due to cortical hypoxia and loss of cortical control or to the failure of brainstem inhibitions is unknown. Consistent with previous reports, EEG monitoring conducted in selected patients in the apparent seizure group failed to disclose characteristic epileptiform discharges. As in prior studies, neurologic symptoms did not recur in those patients treated for vasodepressor syncope.11,13 With the exception of the patient who had a dysarthric transient ischemic attack on tilt table testing, the patients in the current study who were followed up had no further episodes of primary neurologic-type events during adequate β-blocker or mineralocorticoid therapy, further supporting the concept that these events do not represent a manifestation of underlying central nervous system disease.
Complete neurologic evaluations and follow-up were not available on all patients. While it is possible that some of these patients may have had a true seizure disorder, the absence of a postictal state after the tilt-induced event and the prevention of recurrent symptoms by β-blocker or mineralocorticoid therapy in all but 1 patient makes this unlikely. Furthermore, patients with a history of tonic-clonic seizure–like activity had experienced symptom persistence while taking antiepileptic medications before tilt table testing. Successful suppression of events may reflect the correct diagnosis of vasodepressor syncope presenting as seizure, and more complete long-term follow-up would further support this hypothesis. In the absence of continuous and instantaneous hemodynamic monitoring, we cannot exclude the possibility that transient changes in blood pressure occurred in association with neurologiclike events but went undetected by our monitoring protocol.
The retrospective nature of this study may have resulted in inadequate documentation of all potential seizurelike or atypical neurologic events at the time of tilt table testing. However, given the standardized recording procedures used in our laboratory and the dramatic appearance of such events, a significant underestimate is unlikely. The patient population for this study excluded adolescents and children. The results, therefore, only apply to adults.
Finally, the observed frequency of neurologic events in this study is substantially lower than that seen in other studies and reflects the fact that this group was selected for the evaluation of syncope and not for seizure or other neurologic symptoms.5,6 Given the frequent occurrence of vasodepressor syncope in the general population and the frequency of neurologic events that may be associated with vasodepressor syncope, this diagnosis should be considered as a possible cause of seizure-like activity of all varieties for which an underlying neurologic cause is not identified, and tilt table testing should be considered early in the evaluation in such cases.
As described in this report, the diversity and frequency of seizurelike and other apparent neurologic events occurring in association with positive tilt table test results is clinically important. Apparent tonic-clonic seizures occurring during tilt table testing are due to profound reductions in cerebral perfusion pressure and need not suggest an underlying neurologic abnormality. Conversely, in patients with atypical neurologic events during tilt table testing, no significant reduction in systolic blood pressure levels at test termination was noted, suggesting that these patients represent a separate group that may require further investigation for an underlying abnormality. Thus, vasodepressor syncope should be considered as a possible cause of unexplained seizurelike activity of all varieties, and tilt table testing should be considered early in the evaluation of such patients.
Corresponding author and reprints: Alan Kadish, MD, Division of Cardiology, Northwestern Memorial Hospital, 251 E Huron St, Suite 8-536, Chicago, IL 60611 (e-mail: email@example.com).
Accepted for publication November 11, 2002.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 9
Customize your page view by dragging & repositioning the boxes below.
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.